4-s-(propionic acid)sulfidocyclophosphamide has been researched along with Heart Failure in 1 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun-Dullaeus, RC; Groscheck, T; Hansen, M; Kropf, S; Luani, B; Meißler, S; Rauwolf, T; Schmeisser, A; Steendijk, P; Tanev, I | 1 |
1 trial(s) available for 4-s-(propionic acid)sulfidocyclophosphamide and Heart Failure
| Article | Year |
|---|---|
Pressure-volume loop validation of TAPSE/PASP for right ventricular arterial coupling in heart failure with pulmonary hypertension.
Topics: Cyclophosphamide; Heart Failure; Humans; Hypertension, Pulmonary; Pulmonary Artery; Stroke Volume; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |